» Articles » PMID: 31482952

Comparison Between Peak Systolic Velocity of the Inferior Thyroid Artery and Technetium-99m Pertechnetate Thyroid Uptake in Differentiating Graves' Disease from Thyroiditis

Overview
Specialty Endocrinology
Date 2019 Sep 5
PMID 31482952
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The differentiation between the various etiologies of thyrotoxicosis, including those with hyperthyroidism (especially Graves' disease [GD], the most common cause of hyperthyroidism) and without hyperthyroidism (like thyroiditis), is an important step in planning specific therapy. Technetium-99m (99mTc) pertechnetate thyroid scanning is the gold standard in differentiating GD from thyroiditis. However, this technique has limited availability, is contraindicated in pregnancy and lactation, and is not helpful in cases with history of recent exposure to excess iodine. The aim of this study was to identify the diagnostic value of the peak systolic velocity of the inferior thyroid artery (PSV-ITA) assessed by color-flow Doppler ultrasound (CFDU) and compare the sensitivity and specificity of this method versus 99mTc pertechnetate thyroid uptake.

Subjects And Methods: We prospectively analyzed 65 patients (46 with GD and 19 with thyroiditis). All patients were evaluated with clinical history and physical examination and underwent 99mTc pertechnetate scanning and measurement of TRAb levels and PSV-ITA values by CFDU. The diagnosis was based on findings from signs and symptoms, physical examination, and 99mTc pertechnetate uptake.

Results: Patients with GD had significantly higher mean PSV-ITA values than those with thyroiditis. At a mean PSV-ITA cutoff value of 30 cm/sec, PSV-ITA discriminated GD from thyroiditis with a sensitivity of 91% and specificity of 89%.

Conclusion: Measurement of PSV-ITA by CFDU is a good diagnostic approach to discriminate between GD and thyroiditis, with sensitivity and specificity values comparable to those of 99mTc pertechnetate thyroid uptake.

Citing Articles

Artificial intelligence-based CT-free quantitative thyroid SPECT for thyrotoxicosis: study protocol of a multicentre, prospective, non-inferiority study.

Oh D, Ryoo H, Chung H, Cho S, Kwon K, Kim J BMJ Open. 2024; 14(10):e089552.

PMID: 39401965 PMC: 11475049. DOI: 10.1136/bmjopen-2024-089552.


A meta-analysis: elucidating diagnostic thresholds of peak systolic flow velocities in thyroid arteries for the discrimination of Graves' disease and destructive thyrotoxicosis.

Li S, Ding Z, Li X, Fu M, Sang L, Yang M Front Endocrinol (Lausanne). 2024; 15:1393126.

PMID: 38911037 PMC: 11190173. DOI: 10.3389/fendo.2024.1393126.


Quantitative Diagnosis Progress of Ultrasound Imaging Technology in Thyroid Diffuse Diseases.

Huang J, Zhao J Diagnostics (Basel). 2023; 13(4).

PMID: 36832188 PMC: 9954877. DOI: 10.3390/diagnostics13040700.


Duplex Hemodynamic Parameters of Both Superior and Inferior Thyroid Arteries in Evaluation of Thyroid Hyperfunction Disorders.

Assem Hussein M, Abdel Hamid A, M Abdel Samie R, Hussein E, Sadik Elsawy S Int J Gen Med. 2022; 15:7131-7144.

PMID: 36110917 PMC: 9470082. DOI: 10.2147/IJGM.S375016.


Hyperthyroidism in children and adolescents: Experience in a university hospital in Colombia.

Garcia J, Sarmiento M, Bello J, Zuluaga N, Forero A, Nino L Biomedica. 2022; 42(2):342-354.

PMID: 35867926 PMC: 9443673. DOI: 10.7705/biomedica.6244.


References
1.
Bogazzi F, Bartalena L, Brogioni S, Burelli A, Manetti L, Tanda M . Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur J Endocrinol. 1999; 140(5):452-6. DOI: 10.1530/eje.0.1400452. View

2.
Baldini M, Castagnone D, Rivolta R, Meroni L, Pappalettera M, Cantalamessa L . Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease. Thyroid. 1998; 7(6):823-8. DOI: 10.1089/thy.1997.7.823. View

3.
Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A . Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. J Endocrinol Invest. 1995; 18(11):857-61. DOI: 10.1007/BF03349833. View

4.
Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueda Y, Adachi T . Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels. J Clin Endocrinol Metab. 1987; 65(2):359-63. DOI: 10.1210/jcem-65-2-359. View

5.
Ueda M, Inaba M, Kumeda Y, Nagasaki T, Hiura Y, Tahara H . The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse. Clin Endocrinol (Oxf). 2005; 63(6):657-62. DOI: 10.1111/j.1365-2265.2005.02397.x. View